Evaluation of relative anti-myeloma activity of high-dose melphalan followed by the first peripheral blood stem cell transplantation, as compared with the second transplantation, and to VAD chemotherapy

By Awedan A.   Krol M.   Blajer B.   Rokicka M.   Torosian T.   Urbanowska E.   Wiktor-Jedrzejczak W.  

Transplantation Proceedings, Vol. 35, Iss. 6, 2003-09 ,pp. : 2349-2351

Elsevier

Access to resources Recommend Favorite

High-Dose Chemotherapy Followed by Autologous Hematopoietic Stem-Cell Transplantation for the Treatment of Solid Tumors in Adults: A Critical Review

By  

Current Stem Cell Research & Therapy, Vol. 2, Iss. 1, 2007-01 ,pp. : 65-82

Bentham Science Publishers

Access to resources Recommend Favorite

Relation Between Hematological Recovery and Number of Transplanted Mononuclear Cells in Patients after High Dose Chemotherapy with Peripheral Blood Stem Cell (PBSC) Rescue

By Koumakis G.   Filis J.   Vassilomanolakis M.   Papanastasiou K.   Hajichristou H.   Barbounis V.   Stamatellou M.   Efremidis A.P.  

Blood Cells, Molecules, and Diseases, Vol. 21, Iss. 3, 1995-12 ,pp. : 235-238

Academic Press

Access to resources Recommend Favorite

The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma

By Ritchie D.   Seymour J.   Grigg A.   Roberts A.   Hoyt R.   Thompson S.   Szer J.   Prince H.  

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 101-105

Springer Publishing Company

Access to resources Recommend Favorite

High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival

By Kim Min   Kim Shin   Lee Sung   Sym Sun   Lee Dae   Jang Seongsoo   Park Chan   Chi Hyun   Huh Jooryung   Suh Cheolwon  

Annals of Hematology, Vol. 86, Iss. 6, 2007-06 ,pp. : 435-442

Springer Publishing Company

Access to resources Recommend Favorite